Dipl.-Biochem., Paul-Ehrlich-Institut, Langen Dr. rer. nat Jessica Rößler, Eppendorf Dr. Mathewos Tessema, PhD, Lung Cancer Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA [...] Schwerpunktprofessur Molekularpathologie Kontakt: Prof. Dr. Ulrich Lehmann Institut für Pathologie Medizinische Hochschule Hannover Carl-Neuberg-Str. 1 D-30625 Hannover Tel.: +49-(0)511-532-4475 Fax: [...] der MHH 2008 wurde ich Ende 2009 zum ordentlichen Universitätsprofessor für Molekularpathologie am Institut für Pathologie der Medizinischen Hochschule Hannover berufen. In dieser Funktion leite ich eine

Dr. med. Thomas F. Schulz Klinik / Institut: Institut für Virologie, MHH Wir wollen breit neutralisierende, d.h. gegen verschiedene Coronaviren schützende, humane monoklonale Antikörper als rekombinante [...] idaten gegen SARS-CoV-2 Projektleitung: Prof. Dr. Reinhold Förster Klinik / Institut: Institut für Immunologie Das Institut für Immunologie testet in Kooperation mit der Ludwig-Maximilians-Universität [...] Interface cultures of human primary distal respiratory epithelial for in vitro modelling of SARS-CoV2 infection Projektleitung: Prof. Ulrich Martin, Dr. Ruth Olmer Klinik / Institut: HTTG/ LEBAO Eine Infektion

physiological function and pathophysiological dysfunction of ion channels that are clinically relevant for human diseases. We focus on endo-lysosomal cation channels such as ligand-gated two-pore-loop channels [...] channels (Nav) and chloride channels (CLC). Our work relates to a broad spectrum of clinically relevant human diseases prevalent in western countries such as non-alcoholic fatty liver hepatitis, hyperlipoproteinemia [...] pain as well as rare diseases such as Ebola hemorrhagic fever, Brugada syndrome and Bartter syndrome. For these projects, we utilize a series of preclinical models combining electrophysiological, protein

(2017). Inner tegument proteins of Herpes Simplex Virus are sufficient for intracellular capsid motility in neurons but not for axonal targeting. PLoS Pathog 13, e1006813. 14. Buchmann, B., Dohner, K [...] Wedemeyer, H., Ciesek, S., and von Hahn, T. (2017). A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection. Antiviral Res 141, 116-123. 15. Budida [...] Rovis, T., Jonjic, S., and Messerle, M. (2016). The Essential Human Cytomegalovirus Proteins pUL77 and pUL93 Are Structural Components Necessary for Viral Genome Encapsidation. J Virol 90, 5860-5875. 25. Doll

therapy. Final exam June 2020. Michelangelo Marasco ITALY Supervisor: Prof. Dr. Teresa Carlomagno, Institute for Organic Chemistry / BMWZ, Leibniz Universität Hannover, Project: Structural basis of the activation [...] : Prof. Dr. Christine Falk, IFB-Tx, OE 8889, Project: T and NK cell-mediated immune responses of human lung transplant recipients in vivo - impact on the development of transplant arteriosclerosis. Final [...] Dr. Hildegard Büning, Experimental Hematology, OE 6960, Project: Targeting HIV Integration sites for long term remission and cure. Final exam June 2020. Muhammad Faisal PAKISTAN Supervisor: Prof. Dr.

JH; for the European Society of Pathology Task Force on Quality Assurance in Molecular Pathology and the Royal College of Pathologists: Guidance for laboratories performing molecular pathology for cancer [...] Bröcker V , Klempnauer J, Winkler M, Tiede A: Recombinant human antithrombin prevents xenogenic activation of hemostasis in a model of pig-to-human kidney transplantation. Xenotransplantation 2014; 21(4): [...] Sundarasetty BS, Witte T, Ganser A, Stripecke R: Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation. J Immunol 2014; 192(10): 4636-4647

Björn Zorn (2012) MPI for Chemical Energy Conversion, Mülheim Dr. Giulia Falorsi (2016) PhD at Universita’ degli Studi Di Siena, Italy Dr. Dmitry Soloviov (2016) Joint Institute for Nuclear Research, Dubna [...] Hannover, Germany Dr. Johannes Greve (2018-2021 Dr. rer. nat. in the Manstein group) Group leader, Institute for Biophysical Chemistry, MHH, Hannover, Germany Postdoctoral Research Assistants Postdoctoral Research [...] at the Max Planck Institute of Biochemistry, Munich, Germany Prof. Dr. Matthias Preller (2009-2012 Dr. rer. nat. in the Manstein group) Professor of Structural Bioinformatics, Centre for Structural Systems

die ärztliche Tätigkeit: ethische Aspekte Referentin: Prof. Dr. Dr. Sabine Salloch, Leiterin des Instituts für Ethik, Geschichte und Philosophie der Medizin, MHH 26. Mai 2021 – 17:00: Robotik in der Medizin [...] Petra Verdonk: Inklusion in der Medizinischen Ausbildung (auf Englisch) Markus Ahlers (Doktorand, Institut für Philosophie, Leibniz Universität Hannover): Bias in der Datenverarbeitung 2020 26. August 2020 [...] Universitätsklinikum Essen, ehem. Präsidentin der bvmd Dr. Marianne Behrends, Peter L. Reichertz Institut für Med. Informatik der MHH und der TU Braunschweig & Prof'in Dr. Sandra Steffens, Curriculumse

Wilhelm J, Chakraborty T, Warnecke G, Gottlieb J, Padberg W, Grau V: A relevant experimental model for human bronchiolitis obliterans syndrome. J Heart Lung Transplant 2013; 32(11): 1131-1139 Bachmann S, Panzica [...] Therapeutic Target for the Prevention of Obliterative Airway Disease. Transplantation 2013; 95(2): 285-292 Hussein K , Granot G, Shpilberg O, Kreipe H : Clinical utility gene card for: familial polycythaemia [...] 462(1): 27-37 van Krieken JH, Siebers AG, Normanno N; Quality Assurance for Molecular Pathology group: European consensus conference for external quality assessment in molecular pathology. Ann Oncol 2013;

asked by this panel. For case reports: The Joanna Briggs Institute Critical Appraisal Tool for case reports For case series: The Joanna Briggs Institute Critical Appraisal Tool for case series Tools will [...] / RATIONALE In 2013 the AAN consensus criteria for diagnosis of PML were published. This was a landmark achievement that established two approaches for diagnosis: the first based on characteristic hi [...] of JCV-related disease. Further, the development of robust pharmacovigilance programs for patients at highest risk for PML have taught to detect the earliest, even preclinical stages of disease. Taken together